# Nobel medicine prize goes to Victor Ambros and Gary Ruvkun for microRNA discovery
*Event date: 2024-10-07*
The 2024 Nobel Prize in physiology or medicine was awarded to US scientists Victor Ambros and Gary Ruvkun for their work on the discovery of microRNA, according to CNN's report on the announcement. The Nobel committee said the molecule governs how cells in the body function, putting a foundational piece of biology back in the spotlight.
That is the main verified fact in the supplied packet, and it is enough to explain why the prize matters. Nobel medicine awards are not given for incremental lab results; they tend to recognize discoveries that change how scientists understand life itself. In this case, the committee chose to honor two researchers whose work on microRNA helped reshape modern cell biology.
The article should keep the explanation broad and accurate. The source says microRNA governs how cells function, which means the prize is about a mechanism that influences biological behavior at a very basic level. The report does not include a longer technical breakdown, so the article should not drift into jargon or imply conclusions that were not stated in the excerpt.
The award also tells a larger story about scientific recognition. Ambros and Ruvkun are American biologists, and the Nobel committee's decision highlights research that may have been obscure when it began but became central enough to merit the field's most prominent prize. For readers, that is a reminder that basic biological research can take years to reveal its full importance.
The timing matters too. Nobel announcements often become a quick snapshot of where scientific prestige is landing in a given year, and the 2024 medicine prize pointed squarely at gene regulation and cellular control. Even without a detailed explanation in the packet, the headline itself signals that the committee viewed the discovery as transformative rather than merely useful.
Because the supplied evidence is brief, the article should not claim more than it can support. It does not list the prize amount, the committee's wording, the location of the announcement or any later reception from the winners. What it does establish is enough: two American biologists were named Nobel laureates for the discovery of microRNA.
That spare fact still carries weight. The Nobel Prize in medicine is often a marker of work that has moved from specialist circles into the center of the discipline. Ambros and Ruvkun's recognition places microRNA alongside other discoveries that changed the vocabulary of modern biology. For scientists, that kind of validation can shift how a field is taught, funded and remembered.
The article can therefore stay compact and still feel complete. On Oct. 7, 2024, the Nobel committee honored Victor Ambros and Gary Ruvkun for discovering microRNA, and CNN's report framed the molecule as one that governs how cells function. That is the supported news line, and it is enough to anchor a precise, readable report.
Because the supplied evidence is brief, the article should not claim more than it can support. It does not list the prize amount, the committee's wording, the location of the announcement or any later reception from the winners. What it does establish is enough: two American biologists were named Nobel laureates for the discovery of microRNA.
